Literature DB >> 19170514

Application of physicochemically modified silicon substrates as reverse-phase protein microarrays.

A Jasper Nijdam1, Michael R Zianni, Edward E Herderick, Mark M-C Cheng, Jenifer R Prosperi, Fredika A Robertson, Emanuel F Petricoin, Lance A Liotta, Mauro Ferrari.   

Abstract

Physicochemically modified silicon substrates can provide a high quality alternative to nitrocellulose-coated glass slides for use in reverse-phase protein microarrays. Enhancement of protein microarray sensitivities is an important goal, especially because molecular targets within patient tissues exist in low abundance. The ideal array substrate has a high protein binding affinity and low intrinsic background signal. Silicon, which has low intrinsic autofluorescence, is being explored as a potential microarray surface. In a previous paper ( Nijdam , A. J. ; Cheng , M. M.-C. ; Fedele , R. ; Geho , D. H. ; Herrmann , P. ; Killian , K. ; Espina , V. ; Petricoin , E. F. ; Liotta , L. A. ; Ferrari , M. Physicochemically Modified Silicon as Substrate for Protein Microarrays . Biomaterials 2007 , 28 , 550 - 558 ), it is shown that physicochemical modification of silicon substrates increases the binding of protein to silicon to a level comparable with that of nitrocellulose. Here, we apply such substrates in a reverse-phase protein microarray setting in two model systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19170514      PMCID: PMC2693459          DOI: 10.1021/pr800455y

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  29 in total

Review 1.  Protein microarrays and proteomics.

Authors:  Gavin MacBeath
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

Review 2.  Protein microarrays: meeting analytical challenges for clinical applications.

Authors:  Lance A Liotta; Virginia Espina; Arpita I Mehta; Valerie Calvert; Kevin Rosenblatt; David Geho; Peter J Munson; Lynn Young; Julia Wulfkuhle; Emanuel F Petricoin
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

3.  The use of nanocrystals in biological detection.

Authors:  Paul Alivisatos
Journal:  Nat Biotechnol       Date:  2004-01       Impact factor: 54.908

4.  Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.

Authors:  Christian Gulmann; Virginia Espina; Emanuel Petricoin; Dan L Longo; Mariarita Santi; Turid Knutsen; Mark Raffeld; Elaine S Jaffe; Lance A Liotta; Andrew L Feldman
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

Review 5.  The amplified peptidome: the new treasure chest of candidate biomarkers.

Authors:  David H Geho; Lance A Liotta; Emanuel F Petricoin; Weidong Zhao; Robyn P Araujo
Journal:  Curr Opin Chem Biol       Date:  2006-01-18       Impact factor: 8.822

6.  Antigen microarrays for serodiagnosis of infectious diseases.

Authors:  Letizia Mezzasoma; Tito Bacarese-Hamilton; Manlio Di Cristina; Ruggero Rossi; Francesco Bistoni; Andrea Crisanti
Journal:  Clin Chem       Date:  2002-01       Impact factor: 8.327

Review 7.  Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

Authors:  Emanuel F Petricoin; Verena E Bichsel; Valerie S Calvert; Virginia Espina; Mary Winters; Lynn Young; Claudio Belluco; Bruce J Trock; Marc Lippman; David A Fishman; Dennis C Sgroi; Peter J Munson; Laura J Esserman; Lance A Liotta
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

8.  Physicochemically modified silicon as a substrate for protein microarrays.

Authors:  A Jasper Nijdam; Mark Ming-Cheng Cheng; David H Geho; Roberta Fedele; Paul Herrmann; Keith Killian; Virginia Espina; Emanuel F Petricoin; Lance A Liotta; Mauro Ferrari
Journal:  Biomaterials       Date:  2006-09-20       Impact factor: 12.479

9.  Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.

Authors:  Hongbin Zha; Mark Raffeld; Lu Charboneau; Stefania Pittaluga; Larry W Kwak; Emanuel Petricoin; Lance A Liotta; Elaine S Jaffe
Journal:  Lab Invest       Date:  2004-02       Impact factor: 5.662

10.  Polypeptide semicarbazide glass slide microarrays: characterization and comparison with amine slides in serodetection studies.

Authors:  Xavier Duburcq; Christophe Olivier; Rémi Desmet; Matej Halasa; Olivier Carion; Bruno Grandidier; Thomas Heim; Didier Stiévenard; Claude Auriault; Oleg Melnyk
Journal:  Bioconjug Chem       Date:  2004 Mar-Apr       Impact factor: 4.774

View more
  4 in total

1.  In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice.

Authors:  T Tanaka; B Godin; R Bhavane; R Nieves-Alicea; J Gu; X Liu; C Chiappini; J R Fakhoury; S Amra; A Ewing; Q Li; I J Fidler; M Ferrari
Journal:  Int J Pharm       Date:  2010-09-29       Impact factor: 5.875

2.  Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation.

Authors:  Biana Godin; Jianhua Gu; Rita E Serda; Rohan Bhavane; Ennio Tasciotti; Ciro Chiappini; Xuewu Liu; Takemi Tanaka; Paolo Decuzzi; Mauro Ferrari
Journal:  J Biomed Mater Res A       Date:  2010-09-15       Impact factor: 4.396

3.  Proteomics: challenges, techniques and possibilities to overcome biological sample complexity.

Authors:  Kondethimmanahalli Chandramouli; Pei-Yuan Qian
Journal:  Hum Genomics Proteomics       Date:  2009-12-08

Review 4.  Evaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical use.

Authors:  Samantha Spindel; Kim E Sapsford
Journal:  Sensors (Basel)       Date:  2014-11-25       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.